drugset / Trial / NCT01246804
The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to evaluate the effect of ginkgo biloba (steady state) on the pharmacokinetics of a single dose of the UGT-substrate raltegravir. Furthermore the safety profile of the combination is studied.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-03
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgo Biloba Extract | Traditional medicine (herbal / TCM) | 120 mg | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |